Assessment of clinical benefit, cost and uptake of biosimilars versus reference biologics in immune-mediated inflammatory diseases in China - Du, Xin; Luo, Xingxian; Guo, Qixiang; Jiang, Xiaomeng; Su, Ziling; Zhou, Weiting; Wang, Zhongjian; Li, Jiarun; Yang, Yue; Zhang, Yi (Frontiers in Public Health, 2024)